Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Delhi HC Restrains Use of CALDIMUST Trademark Deceptively Similar to Mankinds CALCIMUST

Mankind Pharma donates Rs 1 crore to Chief Minister Relief Fund in Assam

Ruchika Sharma14 Aug 2020 12:26 PM IST

Guwahati: Mankind Pharma, the fourth largest pharmaceutical company of India, has come forward to donate Rs 1 Crore for Assam flood relief.The...

Zydus Cadila gets USFDA nod to Sevelamer Carbonate Tablets for controlling phosphorus in CKD patients

Ruchika Sharma14 Aug 2020 11:43 AM IST

It helps prevent hypocalcemia caused by elevated phosphorus.

Novavax, SK bioscience collaborate for COVID-19 Vaccine Candidate

Ruchika Sharma14 Aug 2020 9:15 AM IST

Under the terms of the agreement, SK bioscience will manufacture the vaccine antigen component for use in the final drug product globally during the...

US inks deal with Moderna for 100 million doses of COVID vaccine: Trump

Ruchika Sharma14 Aug 2020 9:00 AM IST

Washington: The United States has made an agreement with the pharmaceutical company Moderna to deliver 100 million doses of their novel coronavirus...

Maha Govt to soon cap price for masks, sanitizers: Health Minister Rajesh Tope

Ruchika Sharma13 Aug 2020 2:28 PM IST

While addressing a press conference, Tope said, "We have reduced the cost of testing from Rs 2,200 to Rs 1,900. Initially, it was Rs 4,000. Soon we...

Mankind Pharma joins hands with Daewoong Pharma for clinical trial of Covid drug Niclosamide

Ruchika Sharma13 Aug 2020 12:01 PM IST

"We are excited to collaborate with Daewoong Pharmaceutical Co Ltd to bring novel formulation of Niclosamide(DWRX2003) for the treatment of Covid-19...

Lupin unveils asthma drug Zileuton ER Tablets

Ruchika Sharma13 Aug 2020 11:53 AM IST

The tablet is indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older.

COVID-19: Vir Biotech to begin study of therapy candidate VIR-7831 in August

Ruchika Sharma13 Aug 2020 11:00 AM IST

US: Vir Biotechnology Inc said on Tuesday it plans to start a mid-to-late stage trial of its Covid-19 drug candidate in August, as drugmakers...

Govt to discuss procurement, logistics, priority groups for Covid-19 vaccine

Ruchika Sharma13 Aug 2020 9:00 AM IST

The committee on vaccine administration will engage with all stakeholders including state governments and vaccine manufacturers and its terms of...

Bayer to acquire Biotech KaNDy Therapeutics for over Rs 3180 crore

Ruchika Sharma12 Aug 2020 3:50 PM IST

Whippany: Bayer and KaNDy Therapeutics Ltd, a UK clinical-stage biotech company, has announced that Bayer will acquire KaNDy Therapeutics...

COVID-19 Battle: Everest Organics develops Remdesivir API

Ruchika Sharma12 Aug 2020 1:24 PM IST

Mumbai: Pharma major, Everest Organics on Monday said that Remdesivir API has been successfully developed in the R & D facility of the...

AP: Bogus Sanitizer laced with methanol claims lives of 16, 10 held

Ruchika Sharma12 Aug 2020 12:02 PM IST

Amaravati: Spurious sanitiser blended with methanol caused the death of at least 16 people who consumed it in lieu of liquor in Prakasam district in...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok